Drug Injury Watch: New Obesity Drug Qsymia / Qsiva Gets Gets Negative Opinion By European Medicines Agency (EMA)

Combination Pill Of Topamax And Phentremine Was Approved By FDA, But EMA Points To Heart Side Effects, Birth Defects, And Other Safety Issues

http://www.drug-injury.com/druginjurycom/2012/10/qsymia-diet-pill-topamax-topiramate-phentermine-phen-qsiva-ema-fda-safety-issues.html